Carl-Johan Gustafson
Chief Executive Officer at NATTARO LABS AB
Carl-Johan Gustafson active positions
Companies | Position | Start | End |
---|---|---|---|
NATTARO LABS AB | Chief Executive Officer | 2014-12-31 | - |
Investor Relations Contact | 2014-12-31 | - | |
MVIC AB
MVIC AB Miscellaneous Commercial ServicesCommercial Services MVIC AB is an inhalation CRO and partner with over 70 project managers and specialists in discovery, formulation, regulatory, device, and product development. MVIC is based in Stockholm, SE, and has GMP facilities, well-equipped labs, advanced instrumentation, and highly skilled staff. The Swedish company has extensive experience in inhalation product testing and characterization, with standardized procedures or customized to customer requirements. The private company is a team of 70 inhalation experts, 27 with a PhD, covering areas from discovery up to late-phase development. | Director/Board Member | 2018-12-31 | - |
Career history of Carl-Johan Gustafson
Training of Carl-Johan Gustafson
University of Lund | Graduate Degree |
ESCP Europe Campus Paris | Undergraduate Degree |
Statistics
International
Sweden | 4 |
France | 2 |
Operational
Chief Executive Officer | 1 |
Investor Relations Contact | 1 |
Graduate Degree | 1 |
Sectoral
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
NATTARO LABS AB | Health Technology |
Private companies | 1 |
---|---|
MVIC AB
MVIC AB Miscellaneous Commercial ServicesCommercial Services MVIC AB is an inhalation CRO and partner with over 70 project managers and specialists in discovery, formulation, regulatory, device, and product development. MVIC is based in Stockholm, SE, and has GMP facilities, well-equipped labs, advanced instrumentation, and highly skilled staff. The Swedish company has extensive experience in inhalation product testing and characterization, with standardized procedures or customized to customer requirements. The private company is a team of 70 inhalation experts, 27 with a PhD, covering areas from discovery up to late-phase development. | Commercial Services |
- Stock Market
- Insiders
- Carl-Johan Gustafson
- Experience